4-Acetamidoacetophenone, 4-acetylbenzenesulfonamide, and acetohexamide and the resp. reduced compounds, 4-substituted α-hydroxyethylphenyl derivatives, are in a reversible drug-metabolite relationship in rats.The pharmacokinetic profiles of these agents were studied after intraportal (pv) administration in comparison with those after i.v. administration using an interconversion model.Fundamental clearances, CL10, CL12, CL20 and CL21, were calculated using four AUC (area under the plasma concentration-time curve) values obtained after i.v. administration of the drug and preformed metabolite.The hepatic available fraction of parent drug, FH1 and sequential hepatic available fraction of its metabolite, FH2, also were estimated